GO:0090265 positive regulation of immune complex clearance by monocytes and macrophages: Immune Complex Clearance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090265 describes any process that increases the rate, frequency, or extent of immune complex clearance by monocytes or macrophages.
• Macrophages are central effectors of immune complex clearance, and their dysfunction is linked to lupus nephritis and other immune-complex diseases.
• Circulating immune complexes are measurable in patients and correlate with immune function, as shown in untreated Hodgkin's disease.
• Monocyte signaling pathways, including STAT1 and TLR4/TLR2, modulate the inflammatory context in which immune complexes are handled.
• Reduced optineurin expression in macrophages impairs pro-inflammatory cytokine release, illustrating how intracellular regulators shape monocyte/macrophage function.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of candidate genes in immune complex clearance.
Description
GO:0090265, positive regulation of immune complex clearance by monocytes and macrophages, is a biological process term that captures the mechanisms by which monocytes and macrophages accelerate the removal of immune complexes. Immune complexes are lattices of antigen and antibody that, when not cleared efficiently, can deposit in tissues and drive inflammation. Monocytes and macrophages are professional phagocytes that bind, internalize, and degrade these complexes, and the positive regulation of this process is essential for immune homeostasis. Understanding GO:0090265 is important because defects in immune complex clearance are associated with autoimmune and inflammatory pathology, including lupus nephritis, where macrophage function is a key determinant of disease. Moreover, clinical studies have linked circulating immune complex levels to immune status in conditions such as untreated Hodgkin's disease, underscoring the broader relevance of this process. At the molecular level, monocyte signaling pathways such as STAT1 and TLR4/TLR2 influence the inflammatory milieu and the efficiency of immune complex handling. Intracellular regulators such as optineurin further modulate macrophage cytokine release, which can indirectly affect clearance capacity. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0090265, its mechanisms, key genes, disease links, and experimental models.
positive regulation of immune complex clearance by monocytes and macrophages At A Glance
| GO ID | GO:0090265 |
|---|---|
| GO term | positive regulation of immune complex clearance by monocytes and macrophages |
| Ontology | biological_process |
| Synonym | none |
| Major function | Enhances the rate, frequency, or extent of immune complex clearance by monocytes or macrophages |
| Related cell types | Monocytes and macrophages |
| Related process | Immune complex clearance |
| Disease relevance | Lupus nephritis, autoimmune and inflammatory conditions |
| Experimental models | CRISPR knockout, knock-in, overexpression in monocyte/macrophage lines |
What Is GO:0090265?
GO:0090265 is defined as any process that increases the rate, frequency, or extent of the process of immune complex clearance by monocytes or macrophages. In other words, it encompasses the cellular and molecular events that enhance the ability of these phagocytes to recognize, bind, internalize, and degrade immune complexes, thereby promoting their removal from circulation and tissues.
Why Is positive regulation of immune complex clearance by monocytes and macrophages Important in Cell Biology?
GO:0090265 is important because efficient clearance of immune complexes by monocytes and macrophages prevents their deposition in tissues and the subsequent inflammatory damage. In lupus nephritis, macrophages are central to pathogenesis, and their functional state directly influences disease severity. Clinically, circulating immune complex levels have been used as an indicator of immune function in diseases such as untreated Hodgkin's disease. Monocyte signaling pathways, including STAT1 and TLR4/TLR2, shape the inflammatory context that can either promote or impair clearance. Intracellular regulators such as optineurin modulate macrophage cytokine release, which can affect the overall clearance process. Therefore, understanding the positive regulation of immune complex clearance is critical for developing therapies that enhance clearance in autoimmune diseases and for interpreting immune complex biology in infection and cancer.
• Prevents tissue deposition of immune complexes and subsequent inflammation.
• Central to lupus nephritis pathogenesis, where macrophages drive injury.
• Circulating immune complexes reflect immune status in Hodgkin's disease.
• Monocyte STAT1 signaling influences apoptosis and inflammatory responses.
• TLR4/TLR2 pathways modulate self-tolerance and cross-tolerance to infection.
• Optineurin expression in macrophages affects pro-inflammatory cytokine release.
• Relevant to autoimmune diseases, infections, and cancer immunology.
• Provides targets for therapeutic enhancement of clearance.
• Enables mechanistic studies using CRISPR-edited monocyte/macrophage models.
• Links innate immune cell function to adaptive immune complex handling.
What Happens During positive regulation of immune complex clearance by monocytes and macrophages?
Recognition and Binding of Immune Complexes
In simple terms: Monocytes and macrophages first grab onto immune complexes using receptors.
The process begins when monocytes and macrophages recognize immune complexes via Fc gamma receptors and complement receptors. This binding is the initial step that can be positively regulated to enhance clearance. In lupus nephritis, macrophage recognition of immune complexes is a key event in disease pathogenesis. Circulating immune complexes in Hodgkin's disease demonstrate that these complexes are present in patients and can be measured, reflecting immune function.
Signaling Amplification by STAT1 and TLR Pathways
In simple terms: Signals inside the cell can boost the cell's ability to clear complexes.
Intracellular signaling pathways modulate the efficiency of immune complex clearance. STAT1 signaling is amplified in monocytes from HIV-infected patients and is associated with apoptosis, indicating that STAT1 can influence monocyte survival and function. TLR4- and TLR2-mediated pathways induced by myeloid-related protein 8 can promote self-tolerance and cross-tolerance to bacterial infection, which may indirectly affect immune complex handling. These pathways represent potential positive regulators of clearance.
Phagocytosis and Intracellular Degradation
In simple terms: The cell swallows the complex and breaks it down.
After binding, monocytes and macrophages internalize immune complexes through phagocytosis and target them for degradation in lysosomes. This step is the core of clearance. Positive regulation can increase the rate or extent of phagocytosis. Macrophage dysfunction in Crohn's disease, associated with reduced optineurin expression, impairs pro-inflammatory cytokine release, which may alter the phagocytic environment.
Cytokine Modulation and Feedback
In simple terms: The cell releases signals that can either help or hinder clearance.
Cytokines released by monocytes and macrophages can feedback to regulate clearance. In Crohn's disease, reduced optineurin expression in a subset of patients is associated with disrupted pro-inflammatory cytokine release. B7-H1 (PD-L1) expression in the CNS regulates pro-inflammatory cytokine production and alters disease severity in a viral demyelinating disease model, showing that coinhibitory molecules can shape macrophage/monocyte inflammatory output. These feedback loops can positively or negatively regulate immune complex clearance.
Key Genes Involved in GO:0090265 positive regulation of immune complex clearance by monocytes and macrophages
The following genes and proteins have been implicated in monocyte/macrophage function, immune complex handling, or related inflammatory pathways based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STAT1 | Signal transducer and activator of transcription; amplifies monocyte signaling and apoptosis | Associated with apoptosis in monocytes from HIV-infected patients |
| TLR4 | Toll-like receptor 4; mediates responses to bacterial components and modulates tolerance | Induces self-tolerance and cross-tolerance via myeloid-related protein 8 |
| TLR2 | Toll-like receptor 2; mediates responses to bacterial components and modulates tolerance | Induces self-tolerance and cross-tolerance via myeloid-related protein 8 |
| OPTN | Optineurin; regulates pro-inflammatory cytokine release in macrophages | Reduced expression in Crohn's disease macrophages |
| CD274 | B7-H1 (PD-L1); regulates pro-inflammatory cytokine production | Alters severity of Theiler's virus-induced demyelinating disease |
| LYZ | Lysozyme; antibacterial enzyme and marker of monocyte/macrophage activation | Serum lysozyme levels relate to immune function in Hodgkin's disease |
| FCGRs | Fc gamma receptors; bind immune complexes | Central to immune complex recognition by macrophages |
| CRs | Complement receptors; bind complement-opsonized immune complexes | Involved in immune complex clearance |
| MRP8 | Myeloid-related protein 8; induces tolerance via TLR4/TLR2 | Modulates self-tolerance and cross-tolerance |
| MRP14 | Myeloid-related protein 14; partner of MRP8 | Forms heterodimers with MRP8 in inflammatory responses |
| IFN-gamma | Cytokine that primes macrophages | Enhances macrophage function in immune complex clearance |
| TNF-alpha | Pro-inflammatory cytokine released by macrophages | Modulated by optineurin in Crohn's disease |
| IL-6 | Cytokine involved in inflammation | Part of macrophage cytokine release affected by optineurin |
| IL-10 | Anti-inflammatory cytokine | Regulates macrophage inflammatory balance |
| C3 | Complement component 3; opsonin for immune complexes | Facilitates immune complex clearance |
| C1q | Complement component 1q; initiates classical pathway | Binds immune complexes and promotes clearance |
| PD-L1 | Programmed death-ligand 1; coinhibitory molecule | Regulates cytokine production in CNS inflammation |
How Is positive regulation of immune complex clearance by monocytes and macrophages Regulated?
The positive regulation of immune complex clearance by monocytes and macrophages is controlled by multiple signaling pathways. STAT1 signaling is amplified in monocytes from HIV-infected patients and is associated with apoptosis, suggesting that STAT1 can modulate monocyte survival and clearance capacity. TLR4- and TLR2-mediated pathways, activated by myeloid-related protein 8, induce self-tolerance and cross-tolerance to bacterial infection, which can shape the inflammatory environment and influence immune complex handling. Optineurin expression in macrophages regulates pro-inflammatory cytokine release, and its reduction in Crohn's disease is associated with disrupted cytokine profiles. B7-H1 (PD-L1) expression in the CNS regulates pro-inflammatory cytokine production and alters disease severity in a viral demyelinating disease model, indicating that coinhibitory signals can modulate monocyte/macrophage activity. These pathways collectively provide checkpoints that can be targeted to enhance or suppress immune complex clearance.
positive regulation of immune complex clearance by monocytes and macrophages and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STAT1 | HIV infection; monocyte apoptosis | STAT1 knockout or overexpression in monocyte cell lines |
| OPTN | Crohn's disease; macrophage cytokine release | OPTN knockout in macrophage cell lines |
| CD274 | Theiler's virus-induced demyelinating disease; CNS inflammation | CD274 knockout mice or macrophages |
| TLR4/TLR2 | Bacterial infection; self-tolerance | TLR4/TLR2 knockout macrophages |
| FCGRs | Lupus nephritis; immune complex deposition | Fcgr knockout macrophages |
Lupus Nephritis
Lupus nephritis is a prototypical immune complex-mediated disease in which macrophages play a central role. Macrophage dysfunction contributes to the deposition of immune complexes in the kidney and subsequent inflammation. Positive regulation of immune complex clearance by monocytes and macrophages is therefore a potential therapeutic target to reduce renal damage.
Hodgkin's Disease
Circulating immune complexes and serum lysozyme levels have been studied in untreated Hodgkin's disease, showing a relationship to immune function. This suggests that immune complex clearance mechanisms may be altered in cancer and could serve as biomarkers or therapeutic targets.
HIV Infection
In HIV-infected patients, STAT1 signaling is amplified in monocytes and associated with apoptosis, which may impair monocyte function and immune complex clearance. This highlights how viral infections can dysregulate the positive regulation of immune complex clearance.
Crohn's Disease
Reduced optineurin expression in a subset of Crohn's disease patients is associated with disrupted macrophage pro-inflammatory cytokine release. This may affect the inflammatory milieu and the efficiency of immune complex clearance, linking GO:0090265 to inflammatory bowel disease.
From positive regulation of immune complex clearance by monocytes and macrophages-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does STAT1 regulate monocyte apoptosis and clearance? | STAT1 knockout and overexpression in monocyte cell lines |
| Does optineurin modulate macrophage cytokine release? | OPTN knockout in macrophage cell lines |
| Does TLR4/TLR2 signaling affect immune complex handling? | TLR4/TLR2 knockout macrophages |
| Does B7-H1 (PD-L1) regulate cytokine production in CNS inflammation? | CD274 knockout mice |
| Do Fc gamma receptors mediate immune complex clearance? | Fcgr knockout macrophages |
| Can overexpression of clearance receptors enhance immune complex uptake? | Receptor overexpression in macrophage cell lines |
How to Study the positive regulation of immune complex clearance by monocytes and macrophages Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene requirement for immune complex clearance | Identify positive regulators in macrophage cell lines |
| RNA-seq | Transcriptional changes | Profile monocyte/macrophage responses |
| Proteomics | Protein expression and modifications | Detect changes in signaling pathways |
| Phagocytosis assay | Uptake of immune complexes | Measure clearance rate |
| Cytokine ELISA | Secreted cytokine levels | Assess inflammatory output |
| Flow cytometry | Cell surface markers and apoptosis | Evaluate monocyte activation and survival |
| Immunofluorescence | Localization of immune complexes and receptors | Visualize clearance in tissues |
| Western blot | Protein expression and phosphorylation | Confirm signaling changes |
CRISPR Knockout Screening
CRISPR knockout screens can identify genes that positively regulate immune complex clearance. By disrupting candidate genes in monocyte/macrophage cell lines, researchers can measure changes in immune complex uptake and degradation. This approach is informed by pathways such as STAT1 and TLR4/TLR2.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can reveal expression changes in monocytes and macrophages under conditions that modulate clearance. For example, STAT1 signaling is amplified in HIV-infected monocytes, and optineurin expression is reduced in Crohn's disease macrophages, demonstrating the value of profiling.
Functional Phagocytosis Assays
Phagocytosis assays using fluorescently labeled immune complexes measure the rate and extent of uptake by monocytes and macrophages. These assays can be combined with genetic perturbations to test positive regulators. Macrophage function in lupus nephritis provides a disease-relevant context.
Cytokine Release Assays
Cytokine release assays quantify pro-inflammatory and anti-inflammatory cytokines secreted by monocytes/macrophages. Disrupted cytokine release associated with reduced optineurin in Crohn's disease illustrates the utility of this method. B7-H1 regulation of cytokine production in CNS inflammation further supports cytokine profiling.
How CRISPR Can Be Used to Study GO:0090265 positive regulation of immune complex clearance by monocytes and macrophages
Knockout
CRISPR knockout of candidate genes such as STAT1, OPTN, TLR4, or TLR2 in monocyte/macrophage cell lines can test their requirement for positive regulation of immune complex clearance. For example, STAT1 knockout may reduce apoptosis and alter clearance capacity, while OPTN knockout may disrupt cytokine release.
Point Mutation
Point mutations can be introduced to model specific amino acid changes in proteins such as STAT1 or optineurin, allowing structure-function analysis. This is useful for dissecting signaling domains required for positive regulation of immune complex clearance.
Knock-in
Knock-in of tagged or reporter versions of genes like STAT1 or OPTN enables tracking of protein localization and dynamics during immune complex clearance. This can reveal how these proteins are recruited to phagosomes or signaling complexes.
Overexpression
Overexpression of clearance receptors, such as Fc gamma receptors, or signaling molecules like STAT1, can enhance immune complex uptake and degradation. This approach can identify rate-limiting steps in the positive regulation of clearance.
How EDITGENE Supports positive regulation of immune complex clearance by monocytes and macrophages Research
Researchers studying positive regulation of immune complex clearance by monocytes and macrophages-related genes often need to determine whether a candidate gene is causally involved in enhancing clearance or is merely correlated with the phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies in monocyte and macrophage models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of immune complex clearance by monocytes and macrophages research.
Frequently Asked Questions About positive regulation of immune complex clearance by monocytes and macrophages
What is GO:0090265?
GO:0090265 is a Gene Ontology biological process term defined as any process that increases the rate, frequency, or extent of immune complex clearance by monocytes or macrophages.
What genes are involved in positive regulation of immune complex clearance by monocytes and macrophages?
Genes such as STAT1, OPTN, TLR4, TLR2, and CD274 have been implicated in monocyte/macrophage function and related inflammatory pathways.
How is immune complex clearance by macrophages regulated?
It is regulated by signaling pathways including STAT1, TLR4/TLR2, and intracellular regulators such as optineurin, which modulate cytokine release and phagocytic capacity.
What diseases are associated with defective immune complex clearance?
Lupus nephritis, Hodgkin's disease, HIV infection, and Crohn's disease have been linked to altered monocyte/macrophage function and immune complex handling.
What experimental models are used to study GO:0090265?
CRISPR knockout, knock-in, and overexpression in monocyte/macrophage cell lines, as well as phagocytosis and cytokine assays, are commonly used.
How can CRISPR help study positive regulation of immune complex clearance?
CRISPR enables knockout, point mutation, knock-in, and overexpression of candidate genes to test their causal role in enhancing immune complex clearance.
What is the role of STAT1 in monocytes?
STAT1 signaling is amplified in monocytes from HIV-infected patients and is associated with apoptosis, indicating a role in monocyte survival and function.
What is the role of optineurin in macrophages?
Reduced optineurin expression in Crohn's disease macrophages is associated with disrupted pro-inflammatory cytokine release.
How do TLR4 and TLR2 affect immune complex clearance?
TLR4- and TLR2-mediated pathways induced by myeloid-related protein 8 can promote self-tolerance and cross-tolerance to bacterial infection, indirectly influencing immune complex handling.
Why is immune complex clearance important in lupus nephritis?
Macrophages are central to lupus nephritis pathogenesis, and efficient clearance prevents immune complex deposition and subsequent kidney inflammation.
Conclusion
GO:0090265, positive regulation of immune complex clearance by monocytes and macrophages, is a critical biological process that maintains immune homeostasis by accelerating the removal of immune complexes. Dysregulation of this process is linked to diseases such as lupus nephritis, Hodgkin's disease, HIV infection, and Crohn's disease. Key signaling pathways, including STAT1 and TLR4/TLR2, and intracellular regulators such as optineurin, modulate the efficiency of clearance. CRISPR-based models offer powerful tools to dissect the causal roles of these genes. Future research should focus on translating these mechanistic insights into therapeutic strategies that enhance immune complex clearance in autoimmune and inflammatory diseases.
References
- 1. Cheng Y et al.. 2024. Roles of macrophages in lupus nephritis.. Front Pharmacol 15:1477708 PMID: 39611168
- 2. Spinozzi F et al.. 1983. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.. J Clin Lab Immunol 12(2):87-92 PMID: 6644793
- 3. Alhetheel A et al.. 2008. Amplification of the signal transducer and activator of transcription I signaling pathway and its association with apoptosis in monocytes from HIV-infected patients.. AIDS 22(10):1137-44 PMID: 18525259
- 4. Duncan DS et al.. 2011. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.. PLoS One 6(4):e18548 PMID: 21494618
- 5. Coveney AP et al.. 2015. Myeloid-related protein 8 induces self-tolerance and cross-tolerance to bacterial infection via TLR4- and TLR2-mediated signal pathways.. Sci Rep 5:13694 PMID: 26329314
- 6. Smith AM et al.. 2015. Disruption of macrophage pro-inflammatory cytokine release in Crohn's disease is associated with reduced optineurin expression in a subset of patients.. Immunology 144(1):45-55 PMID: 24943399
